{
 "drug": "Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "06/15/2026",
 "dayN": 71,
 "cat": "Neurology",
 "companies": [
  "Amneal Pharmaceuticals"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "06/15/2026",
   "update_type": "New",
   "initial_posting_date": "06/15/2026",
   "package_ndc": "69238-1248-3",
   "generic_name": "Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release",
   "contact_info": "866-525-7270",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA208328"
    ],
    "brand_name": [
     "MEMANTINE AND DONEPEZIL HYDROCHLORIDES EXTENDED-RELEASE"
    ],
    "generic_name": [
     "MEMANTINE AND DONEPEZIL"
    ],
    "manufacturer_name": [
     "Amneal Pharmaceuticals NY LLC"
    ],
    "product_ndc": [
     "69238-1248",
     "69238-1247",
     "69238-1552",
     "69238-1553"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "MEMANTINE HYDROCHLORIDE",
     "DONEPEZIL HYDROCHLORIDE"
    ],
    "rxcui": [
     "1599803",
     "1599805",
     "1805420",
     "1805425"
    ],
    "spl_id": [
     "acd577e1-312c-4d5a-85b5-bc50ef9de545"
    ],
    "spl_set_id": [
     "2335950c-be3b-4248-ad04-e9763aee47d2"
    ],
    "package_ndc": [
     "69238-1248-3",
     "69238-1248-9",
     "69238-1247-3",
     "69238-1247-9",
     "69238-1552-3",
     "69238-1552-9",
     "69238-1553-3",
     "69238-1553-9"
    ],
    "unii": [
     "3O2T2PJ89D",
     "JY0WD0UA60"
    ]
   },
   "update_date": "06/15/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Capsule, Extended Release",
   "presentation": "Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 14 mg (NDC 69238-1248-3)",
   "company_name": "Amneal Pharmaceuticals",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "06/15/2026",
   "update_type": "New",
   "initial_posting_date": "06/15/2026",
   "package_ndc": "69238-1247-3",
   "generic_name": "Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release",
   "contact_info": "866-525-7270",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA208328"
    ],
    "brand_name": [
     "MEMANTINE AND DONEPEZIL HYDROCHLORIDES EXTENDED-RELEASE"
    ],
    "generic_name": [
     "MEMANTINE AND DONEPEZIL"
    ],
    "manufacturer_name": [
     "Amneal Pharmaceuticals NY LLC"
    ],
    "product_ndc": [
     "69238-1247",
     "69238-1248",
     "69238-1552",
     "69238-1553"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "MEMANTINE HYDROCHLORIDE",
     "DONEPEZIL HYDROCHLORIDE"
    ],
    "rxcui": [
     "1599803",
     "1599805",
     "1805420",
     "1805425"
    ],
    "spl_id": [
     "acd577e1-312c-4d5a-85b5-bc50ef9de545"
    ],
    "spl_set_id": [
     "2335950c-be3b-4248-ad04-e9763aee47d2"
    ],
    "package_ndc": [
     "69238-1248-3",
     "69238-1248-9",
     "69238-1247-3",
     "69238-1247-9",
     "69238-1552-3",
     "69238-1552-9",
     "69238-1553-3",
     "69238-1553-9"
    ],
    "unii": [
     "3O2T2PJ89D",
     "JY0WD0UA60"
    ]
   },
   "update_date": "06/15/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Capsule, Extended Release",
   "presentation": "Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 28 mg (NDC 69238-1247-3)",
   "company_name": "Amneal Pharmaceuticals",
   "status": "To Be Discontinued"
  }
 ]
}